STAAR Surgical Company(STAA)

Sector:

Healthcare

Description:

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Current Price

$57.70

RSI

26.03

Market Capitalization:

3.6B

Beta:

1.01

Volume:

781,178

Analyst Target Price:

$ 103

Economiic Fair Price:


November 02, 2022
November 02, 2022
Q3
N/A
N/A
N/A
N/A
N/A
0.5
10.60 %
4.882
0.107

-2.26 %
37.60 %
-40.35 %
-99.88 %
-99.88 %
-99.38 %

$ 230.5M
41.00 %
$ 163.5M
8.84 %
$ 150.2M
21.16 %
$ 124M
36.80 %
$ 90.6M
9.92 %
$ 82.4M

$ 30.3M
141.63 %
$ 12.5M
-19.66 %
$ 15.6M
48.42 %
$ 10.5M
482.29 %
$ 1.8M
183.81 %
$ -2.2M

$ 31.3M
278.66 %
$ 8.3M
-36.53 %
$ 13M
96.20 %
$ 6.6M
389.16 %
$ -2.3M
81.55 %
$ -12.4M

News

Press Releases

Notable Dates